We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Neoleukin Therapeutics, Inc's financial performance into perspective.
October 20, 2020
October 14, 2020
Neoleukin Therapeutics Announces Abstract Accepted for Presentation at the Society for Immunotherapy of Cancer’s 35th Anniversary Annual Meeting (SITC 2020)
September 10, 2020
September 16, 2020 at 9:30 AM EDT
August 13, 2020 at 8:30 AM EDT